Y. Kita et al.
Methyl 6-benzylamino-12-benzyloxydodecanoate (28): In the same proce-
dure for 23, 28 (240 mg, 90%) was obtained from 17 (210 mg,
0.63 mmol). Colorless crystals; m.p. 31.58C; H NMR (300 MHz, CDCl3):
(FAB): m/z: 368 [M+H]+; HRMS (FAB): m/z: calcd for C19H30O4NS:
368.1899; found: 368.1894.
1
7-Dibenzylamino oxacyclotridecan-2-one (11d): In the same procedure
for 3a, 11d (22 mg, 66%) was obtained from 10d (35 mg, 0.085 mmol).
Colorless oil; 1H NMR (300 MHz, CDCl3): d=1.08–1.52 (m, 16H), 2.11
(t, J=5.7 Hz, 2H), 2.30–2.36 (m, 2H), 3.24 (d, J=13.5 Hz, 2H), 3.58 (d,
J=13.5 Hz, 2H), 3.65–3.70 (m, 1H), 4.06–4.12 (m, 1H), 7.08–7.26 ppm
(m, 10H); 13C NMR (75.5 MHz, CDCl3): d=23.2, 23.7, 24.4, 25.4, 25.7,
27.0, 27.1, 27.6, 34.9, 53.6 (2C), 53.8, 63.9, 126.6 (2C), 128.0 (4C), 129.0
(4C), 140.9 (2C), 173.5 ppm; IR (KBr): n˜ =2932, 2855, 1730 cmꢀ1; LRMS
(FAB): m/z: 394 [M+H]+; HRMS (FAB): m/z: calcd for C26H36O2N:
394.2755; found: 394.2740.
d=1.14–1.55 (m, 16H), 1.96 (s, 3H), 2.22 (t, J=7.5 Hz, 2H), 2.42 (t, J=
5.4 Hz, 1H), 3.37 (t, J=6.6 Hz, 2H), 3.57 (s, 3H), 3.65 (s, 2H), 4.41 (s,
2H), 7.12–7.25 ppm (m, 10H); 13C NMR (75.5 MHz, CDCl3): d=25.1,
25.2, 25.5, 26.1, 29.7, 29.7, 3.5, 33.8, 34.0, 51.1, 51.4, 56.5, 70.4, 72.8, 126.7,
127.4, 127.5, 128.1 (2C), 128.3 (2C), 128.3 (2C), 128.3, 138.6, 140.9,
174.1 ppm; IR (KBr): n˜ =2932, 2856, 1738 cmꢀ1; LRMS (FAB): m/z: 426
[M+H]+; HRMS (FAB): m/z: calcd for C27H40O3N: 426.2998; found:
426.3015.
Methyl
6-(benzyl-tert-butoxycarbonylamino)-12-hydroxydodecanoate
(29): Pd(OH)2 (0.1 g) and di-tert-butyldicarbonate (0.16 mL, 0.71 mmol)
were added to the solution of 28 (200 mg, 0.47 mmol) in MeOH (4.7 mL)
at room temperature. The resulting mixture was stirred at room tempera-
ture for 12 h under a hydrogen atmosphere (4.0 atm). The mixture was
passed through celite pad and the filtrate was concentrated in vacuo. Pu-
rification of the residue by SiO2 column chromatography (hexane/AcOEt
2:1) gave 29 (130 mg, 64%) as a colorless oil. 1H NMR (270 MHz,
CDCl3): d=1.23–1.48 (m, 16H), 1.40 (s, 9H), 2.16–2.18 (m, 2H), 2.37 (s,
1H), 3.55 (t, J=6.5 Hz, 2H), 3.62 (s, 3H), 3.62 (m, 1H), 4.22 (s, 1H),
4.32 (s, 1H), 7.27 ppm (s, 5H); 13C NMR (67.8 MHz, CDCl3): d=24.5,
24.6, 25.5, 26.0, 26.3, 28.2, 28.4, 29.0, 32.5, 32.8*, 33.0, 33.2*, 33.5, 33.8,
46.4, 51.3, 55.8, 62.4, 79.3, 126.3*, 126.5, 126.8, 127.7, 127.8 (2C), 139.5*,
139.8, 155.9*, 156.5, 173.7 ppm (*=minor diastereomer); IR (KBr): n˜ =
3356, 2932, 2858, 1738, 1682 cmꢀ1 LRMS (FAB): m/z: 436 [M+H]+;
HRMS (FAB): m/z: calcd for C25H42O5N: 436.3059; found: 436.3066.
1-Benzyl-7-(6-hydroxyhexyl)azepan-2-one (12): Under a nitrogen atmos-
phere, ethoxyacetylene (59 mL, 0.42 mmol) was slowly added to the solu-
tion of [RuCl2ACHTUNRGTNEUNG(p-cymene)]2 (2.0 mg, 2.8 mmol) in acetone (2.0 mL) at
08C. The resulting mixture was stirred at 08C for 5 min and 10e (45 mg,
0.14 mmol) in acetone (1.2 mL) was slowly added at 08C. The resulting
mixture was stirred at room temperature for 1 h and Ru was filtered
through short neutral SiO2 pad column elucidated by AcOEt. The resi-
due was concentrated in vacuo. The ethoxyvinyl ester (quant, >95%
purity based on 1H NMR analysis) was used without further purification.
The crude EVE was diluted in DCE (10 mL) and slowly added by sy-
ringe pump to the high diluted pTsOH (0.05m in DCE/CH3CN 1:1,
0.32 mL, 0.014 mmol) solution in DCE (20 mL) over 10 h at 808C. Reac-
tion mixture was stirred at 808C for 1 h and cooled to room temperature.
Et3N (ca. 0.016 mmol) was added to the mixture, and the resulting solu-
tion was concentrated in vacuo. Purification of the residue by SiO2
column chromatography (hexane/Et2O 20:1) gave 12 (23 mg, 54%) as a
colorless oil. 1H NMR (270 MHz, CDCl3): d=1.21–1.74 (m, 16H), 2.49–
2.71 (m, 2H), 3.28–3.30 (m, 1H), 3.58 (t, J=6.5 Hz, 2H), 4.06 (d, J=
14.9 Hz, 1H), 5.04 (d, J=14.6 Hz, 1H), 7.22–7.29 ppm (m, 5H);
13C NMR (67.8 MHz, CDCl3): d=23.5, 24.0, 25.6, 27.1, 29.3, 31.6 (2C),
32.6 (2C), 37.8, 58.2, 62.8, 127.1, 128.2 (2C), 128.3 (2C), 138.2,
175.2 ppm; IR (KBr): n˜ =3319, 2930, 2856, 1614 cmꢀ1; LRMS (FAB):
m/z: 304 [M+H]+; HRMS (FAB): m/z: calcd for C19H30O2N: 304.2296;
found: 304.2232.
6-(Benzyl-tert-butoxycarbonylamino)-12-hydroxydodecanoic acid (10a):
In the same procedure for 6a, 10a (115 mg, 100%) was obtained from 29
(130 mg, 0.30 mmol).Colorless oil; 1H NMR (300 MHz, CDCl3): d=1.23–
1.49 (m, 16H), 1.49 (s, 9H), 2.22 (m, 2H), 3.59 (t, J=6.6 Hz, 2H), 4.11–
4.13 (m, 2H), 4.24 (s, 1H), 4.34 (s, 1H), 7.29 ppm (s, 5H); 13C NMR
(75.5 MHz, CDCl3): d=24.4, 25.4, 25.9, 26.2, 28.2, 28.4, 28.9, 32.2, 32.9,
33.2, 33.4, 33.8, 46.4, 53.3, 60.4*, 62.5, 79.6, 126.5, 126.7*, 126.9, 127.9,
128.0, 139.9, 156.2, 156.8*, 178.5 ppm (*=minor diastereomer); IR
(KBr): n˜ =2930, 2860, 1651 cmꢀ1
.
Macrolactonization (Table 5)
Macrolactonization in the total synthesis of (+)-Sch 642305[12] (Table 6)
7-[Benzyl(tert-butoxycarbonyl)amino]oxacyclotridecan-2-one (11a): In
the same procedure for 3a, 11a (575 mg, 85%) was obtained from 10a
(70 mg, 0.17 mmol). Colorless oil; 1H NMR (270 MHz, CDCl3): d=1.31–
1.72 (m, 16H), 1.49 (s, 9H), 2.20–2.38 (m, 1H), 2.38–2.46 (m, 1H), 3.81
(m, 1H)*, 3.95–4.00 (m, 1H), 4.08 (m, 1H), 4.27–4.39 (m, 3H), 7.18–
7.29 ppm (m, 5H); 13C NMR (67.8 MHz, CDCl3): d=23.9, 25.5, 25.9,
26.2, 27.2, 28.4, 28.6, 29.0, 29.7, 32.3, 33.2, 34.8, 47.3, 53.4*, 53.5, 64.2*,
64.5, 79.6, 126.5, 127.3, 128.0 (3C), 139.7*, 140.2, 155.6*, 156.3, 173.5 ppm
(*=minor diastereomer); IR (KBr): n˜ =2932, 2862, 1732, 1688 cmꢀ1; ele-
mental analysis calcd (%) for C24H37NO4: C 71.43, H 9.24, N 3.47; found:
C 71.04, H 9.21, N 3.41.
Since compound 15 is unstable and not easy to purify, crude 15 was oxi-
dized with mCPBA to give a stable 16. The yield of 15 in entry 2 of
Table 6 is the yield of the obtained 16.
O-[(1R)-1,2-Diphenyl-2-oxoethyl]-derivative Sch642305 (16): Under a ni-
trogen atmosphere, ethoxyacetylene (78 mL, 1.12 mmol) was added
slowly to the solution of 14 (20 mg, 0.035 mmol) in DCE (0.7 mL) in the
presence of catalytic amount of [RuCl2ACHTNUGTRENUNG(p-cymene)]2 at 08C. The resulting
mixture was stirred at 408C for 2 h and Ru was filtered by short pad SiO2
column elucidated by AcOEt. The residue was concentrated in vacuo.
The ethoxyvinyl ester (EVE) (quant, >95% purity based on 1H NMR
analysis) was used without further purification.
7-[Benzyl(p-toluenesulfonyl)amino]oxacyclotridecan-2-one (11b)
The crude EVE was diluted in DCE (10 mL) and slowly added by sy-
ringe pump to the high diluted DCE (25 mL) solution in the presence of
TsOH (0.05m in DCE/CH3CN 1:1, 0.08 mL, 0.004 mmol) over 10 h at
808C. The reaction mixture was stirred at 808C for 1 h; cooled to room
temperature, and poured into saturated NaHCO3. The mixture was ex-
tracted by AcOEt. The organic layer was washed with brine, dried over
Na2SO4 and concentrated in vacuo to give 15. 1H NMR (300 MHz,
CDCl3): d=0.78–1.15 (m, 3H), 1.19–2.03 (m, 8H), 2.28–2.40 (m, 2H),
2.56–2.66 (m, 2H), 2.88 (dd, J=15.6, 5.4 Hz, 1H), 3.13 (t, J=11.6 Hz,
1H), 3.71–3.76 (m, 2H), 4.99 (m, 1H), 5.67 (s, 1H), 7.17–7.46 (m, 12H),
7.44 (t, J=7.4 Hz, 1H), 7.77 ppm (d, J=7.2 Hz, 2H); LRMS (FAB): m/z:
557 [M+H]+; HRMS (FAB): m/z: calcd for C34H37O5S: 557.8369; found:
557.2380.
In the same procedure for 3a, 11b (35 mg, 73%) was obtained from 10b
(50 mg, 0.10 mmol). Yellow oil; 1H NMR (270 MHz, CDCl3): d=1.11–
1.71 (m, 16H), 2.05–2.15 (m, 1H), 2.34–2.42 (m, 1H), 2.37 (s, 3H), 3.67–
3.69 (m, 1H), 3.89–3.96 (m, 1H), 4.14–4.24 (m, 1H), 4.21 (d, J=15.9 Hz,
1H), 4.38 (d, J=15.9 Hzm 1H), 7.18–7.33 (m, 7H), 7.63–7.66 ppm (m,
2H); 13C NMR (67.8 MHz, CDCl3): d=21.2, 23.1, 23.4, 23.8, 25.0, 25.4,
26.6, 28.7, 31.6, 34.5, 47.2, 55.5, 64.2, 126.2 (2C), 126.8, 127.4 (2C), 127.8
(2C), 129.0 (2C), 137.7, 138.1, 142.5, 172.9 ppm; IR (KBr): n˜ =2932,
2860, 1728 cmꢀ1; LRMS (FAB): m/z: 458 [M+H]+; HRMS (FAB): m/z:
calcd for C26H36O4NS: 458.2359; found: 458.2370.
7-(p-Toluenesulfonylamino)oxacyclotridecan-2-one (11c): In the same
procedure for 3a, 11c (25 mg, 75%) was obtained from 10c (35 mg,
0.091 mmol). Yellow crystals; m.p. 92.0–92.58C; 1H NMR (300 MHz,
CDCl3): d=1.17–1.63 (m, 16H), 2.12–2.22 (m, 2H), 2.28–2.36 (m, 2H),
2.36 (s, 3H), 3.14–3.15 (m, 1H), 3.91–3.98 (m, 2H), 4.11–4.18 (m, 2H),
4.52 (d, J=8.1 Hz, 1H), 7.23 (d, J=7.3 Hz, 2H), 7.70 ppm (d, J=7.3 Hz,
2H); 13C NMR (75.5 MHz, CDCl3): d=21.5, 21.6, 23.8 (2C), 24.4, 26.1,
27.2, 31.3, 33.4, 34.5, 51.8, 64.5, 126.9 (2C), 129.5 (2C), 138.0, 143.0,
Under nitrogen atmosphere, mCPBA (12 mg, 0.07 mmol) was added to
the solution of the crude 15 in DCE (0.7 mL) at 08C. The resulting mix-
ture was stirred at room temperature for 30 min. Then Et3N (30 mL,
0.20 mmol) was added to the solution. The resulting mixture was stirred
at room temperature for 30 min and poured into saturated aqueous
Na2S2O3. The mixture was extracted by AcOEt. The organic layer was
173.5 ppm; IR (KBr): n˜ =3279, 2939, 2862, 1730, 1713 cmꢀ1
; LRMS
3536
ꢀ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2009, 15, 3526 – 3537